New life sciences investor Vie Ventures eyes at least $75m initial close for debut fund

Life sciences investor Vie Ventures has been launched by former MPM Capital pair Steven St Peter and Luke Evnin, with eyes on bridging VC and disease philanthropy to develop breakthrough therapies for patients.